Small
stocks making big moves on Wednesday, July 15, 2015 (as of 4 pm EST), as
reported by Sean Mason, SmallCapPower.com
Canada Carbon Inc. (TSXV:
CCB) shares climbed 9% to $0.29 on volume of more than 2.6 million shares
Wednesday after the graphite explorer said it has received indicative pricing
of US$12,000 to US$14,000 per metric tonne for 99.9998% graphite as part of its
valuation for the Miller Hydrothermal Lump/Vein. This high-purity graphite is
currently used in high tech electronics industry applications. The indicative
pricing will be included in Canada Carbon’s Preliminary Economic Assessment
(PEA) and mineral resource estimate for the Miller Project, which is currently
underway.
As well,
shares of Immunovaccine Inc. (TSX:
IMV) rose 4% to $1.09 as the clinical stage vaccine and immunotherapy
company announced that the U.S. Food and Drug Administration (FDA) has granted
orphan drug status to Immunovaccine’s lead clinical-stage cancer immunotherapy,
DPX-Survivac, for the treatment of ovarian cancer.
Pangolin Diamonds Corp. (TSXV:
PAN), meanwhile, reported that it has received what it calls “a positive
kimberlite indicator mineral analyses” for its wholly-owned Malatswae Diamond
Project in Botswana. Pangolin stock moved up 17% to $0.035 following the announcement.
